Advertisement
Screener

UTAH MEDICAL PRODUCTS, INC. (UTMD) Amortization

UTAH MEDICAL PRODUCTS, INC. Amortization

UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Amortization of $5.00 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.

Discontinued › Cash Flow › Operating Activities

us-gaap:AdjustmentForAmortization · last filed 2021-11-12

  • UTAH MEDICAL PRODUCTS, INC. amortization for the quarter ending 2021-09-30 was $1.66M, a 1.71% increase year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. amortization for the quarter ending 2021-06-30 was $1.67M, a 3.66% increase year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. amortization for the quarter ending 2021-03-31 was $1.66M, a 2.09% increase year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. amortization for the quarter ending 2020-12-31 was $1.64M, a 0.49% increase year-over-year.
  • UTAH MEDICAL PRODUCTS, INC. amortization for fiscal 2020 was $6.51M, a 6.04% increase from fiscal 2019.
  • UTAH MEDICAL PRODUCTS, INC. amortization for fiscal 2019 was $6.14M, a 180.42% increase from fiscal 2018.
  • UTAH MEDICAL PRODUCTS, INC. amortization for fiscal 2018 was $2.19M, a 3.69% increase from fiscal 2017.
  • UTAH MEDICAL PRODUCTS, INC. amortization for fiscal 2017 was $2.11M, a 4.95% decline from fiscal 2016.
Period endAmortization 3 monthAmortization 6 monthAmortization 9 monthAmortization 9 month as first filedAmortization 12 month
2021-09-30$1.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$3.33M
derived: sum of 2 quarters · filed 2021-11-12
$5.00M
10-Q · filed 2021-11-12
$6.64M
derived: sum of 4 quarters · filed 2021-11-12
2021-06-30$1.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$3.33M
10-Q · filed 2021-08-06
$4.97M
derived: sum of 3 quarters · filed 2021-08-06
$6.61M
derived: sum of 4 quarters · filed 2021-11-12
2021-03-31$1.66M
10-Q · filed 2021-05-11
$3.30M
derived: sum of 2 quarters · filed 2021-05-11
$4.94M
derived: sum of 3 quarters · filed 2021-11-12
$6.55M
derived: sum of 4 quarters · filed 2021-11-12
2020-12-31$1.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26
$3.27M
derived: sum of 2 quarters · filed 2021-11-12
$4.88M
derived: sum of 3 quarters · filed 2021-11-12
$6.51M
10-K · filed 2021-03-26
2020-09-30$1.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$3.25M
derived: sum of 2 quarters · filed 2021-11-12
$4.88M
10-Q · filed 2021-11-12
$6.51M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$1.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$3.24M
10-Q · filed 2021-08-06
$4.87M
derived: sum of 3 quarters · filed 2021-08-06
$6.48M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31$1.63M
10-Q · filed 2021-05-11
$3.26M
derived: sum of 2 quarters · filed 2021-05-11
$4.87M
derived: sum of 3 quarters · filed 2021-05-11
$6.50M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$1.63M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-26
$3.24M
derived: sum of 2 quarters · filed 2021-03-26
$4.87M
derived: sum of 3 quarters · filed 2021-03-26
$6.14M
10-K · filed 2021-03-26
2019-09-30$1.61M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09
$3.24M
derived: sum of 2 quarters · filed 2020-11-09
$4.51M
10-Q/A · filed 2020-11-09
$5.04M
derived: sum of 4 quarters · filed 2021-03-26
2019-06-30$1.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$2.90M
10-Q · filed 2020-08-07
$3.43M
derived: sum of 3 quarters · filed 2021-03-26
$3.96M
derived: sum of 4 quarters · filed 2021-03-26
2019-03-31$1.27M
10-Q · filed 2020-05-08
$1.80M
derived: sum of 2 quarters · filed 2021-03-26
$2.33M
derived: sum of 3 quarters · filed 2021-03-26
$2.89M
derived: sum of 4 quarters · filed 2021-03-26
2018-12-31$528.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26
$1.06M
derived: sum of 2 quarters · filed 2021-03-26
$1.62M
derived: sum of 3 quarters · filed 2021-03-26
$2.19M
10-K · filed 2021-03-26
2018-09-30$535.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$1.09M
derived: sum of 2 quarters · filed 2019-11-07
$1.66M
10-Q · filed 2019-11-07
$2.21M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$558.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$1.13M
10-Q · filed 2019-08-09
$1.67M
derived: sum of 3 quarters · filed 2020-03-16
$2.21M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$570.00K
10-Q · filed 2019-05-09
$1.11M
derived: sum of 2 quarters · filed 2020-03-16
$1.65M
derived: sum of 3 quarters · filed 2020-03-16
$2.17M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$545.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$1.08M
derived: sum of 2 quarters · filed 2020-03-16
$1.60M
derived: sum of 3 quarters · filed 2020-03-16
$2.11M
10-K · filed 2020-03-16
2017-09-30$537.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$1.06M
derived: sum of 2 quarters · filed 2018-11-07
$1.57M
10-Q · filed 2018-11-07
$2.08M
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30$523.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$1.03M
10-Q · filed 2018-08-09
$1.54M
derived: sum of 3 quarters · filed 2019-03-14
$2.08M
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31$508.00K
10-Q · filed 2018-05-09
$1.02M
derived: sum of 2 quarters · filed 2019-03-14
$1.55M
derived: sum of 3 quarters · filed 2019-03-14
$2.14M
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31$509.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$1.04M
derived: sum of 2 quarters · filed 2019-03-14
$1.63M
derived: sum of 3 quarters · filed 2019-03-14
$2.22M
10-K · filed 2019-03-14
2016-09-30$535.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$1.12M
derived: sum of 2 quarters · filed 2017-11-07
$1.71M
10-Q · filed 2017-11-07
$2.34M
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30$587.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.18M
10-Q · filed 2017-08-03
$1.81M
derived: sum of 3 quarters · filed 2018-03-06
$2.45M
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31$592.00K
10-Q · filed 2017-05-05
$1.22M
derived: sum of 2 quarters · filed 2018-03-06
$1.86M
derived: sum of 3 quarters · filed 2018-03-06
$2.49M
derived: sum of 4 quarters · filed 2018-03-06
2015-12-31$630.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
$1.27M
derived: sum of 2 quarters · filed 2018-03-06
$1.90M
derived: sum of 3 quarters · filed 2018-03-06
$2.53M
10-K · filed 2018-03-06
2015-09-30$639.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$1.27M
derived: sum of 2 quarters · filed 2016-11-04
$1.90M
10-Q · filed 2016-11-04
$2.55M
derived: sum of 4 quarters · filed 2017-03-08
2015-06-30$633.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$1.26M
10-Q · filed 2016-08-08
$1.91M
derived: sum of 3 quarters · filed 2017-03-08
$2.60M
derived: sum of 4 quarters · filed 2017-03-08
2015-03-31$626.00K
10-Q · filed 2016-05-06
$1.28M
derived: sum of 2 quarters · filed 2017-03-08
$1.97M
derived: sum of 3 quarters · filed 2017-03-08
$2.66M
derived: sum of 4 quarters · filed 2017-03-08
2014-12-31$655.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
$1.34M
derived: sum of 2 quarters · filed 2017-03-08
$2.04M
derived: sum of 3 quarters · filed 2017-03-08
$2.72M
10-K · filed 2017-03-08
2014-09-30$688.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$1.38M
derived: sum of 2 quarters · filed 2015-11-06
$2.06M
10-Q · filed 2015-11-06
$2.73M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$694.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$1.38M
10-Q · filed 2015-08-07
$2.05M
derived: sum of 3 quarters · filed 2016-03-10
$2.69M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$682.00K
10-Q · filed 2015-05-06
$1.35M
derived: sum of 2 quarters · filed 2016-03-10
$1.99M
derived: sum of 3 quarters · filed 2016-03-10
$2.63M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$670.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$1.31M
derived: sum of 2 quarters · filed 2016-03-10
$1.95M
derived: sum of 3 quarters · filed 2016-03-10
$2.58M
10-K · filed 2016-03-10
2013-09-30$641.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
$1.27M
derived: sum of 2 quarters · filed 2014-11-04
$1.91M
10-Q · filed 2014-11-04
$1.91M
10-Q · filed 2013-11-06
$2.57M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$634.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$1.27M
10-Q · filed 2014-08-08
$1.93M
derived: sum of 3 quarters · filed 2015-03-12
$2.58M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$639.00K
10-Q · filed 2014-05-07
$1.29M
derived: sum of 2 quarters · filed 2015-03-12
$1.95M
derived: sum of 3 quarters · filed 2015-03-12
$2.60M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$656.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$1.31M
derived: sum of 2 quarters · filed 2015-03-12
$1.96M
derived: sum of 3 quarters · filed 2015-03-12
$2.61M
10-K · filed 2015-03-12
2012-09-30$652.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$1.31M
derived: sum of 2 quarters · filed 2013-11-06
$1.96M
10-Q · filed 2013-11-06
$2.60M
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30$654.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$1.30M
10-Q · filed 2013-08-08
$1.95M
derived: sum of 3 quarters · filed 2014-03-12
$2.60M
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31$651.00K
10-Q · filed 2013-05-08
$1.29M
derived: sum of 2 quarters · filed 2014-03-12
$1.95M
derived: sum of 3 quarters · filed 2014-03-12
2011-12-31$642.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12
$1.30M
derived: sum of 2 quarters · filed 2014-03-12
$2.07M
10-K · filed 2014-03-12
2011-09-30$657.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$1.42M
10-Q · filed 2012-11-09
2011-06-30$767.00K
10-Q · filed 2012-08-08
2010-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
$44.00K
10-K · filed 2013-03-07
2010-09-30$33.00K
10-Q · filed 2011-11-07
2009-12-31$34.00K
10-K/A · filed 2012-10-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
PRO DEX INC (PDEX)United States$0.234B13.64
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Profound Medical Corp. (PROF)$0.206B-7.37
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32